Manning & Napier Group's CLBT Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 145,541 shares of Cellebrite DI Ltd. (CLBT) worth $2.62 M, representing 0.03% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 4 quarters.
Based on 13F filings, Manning & Napier Group has maintained this position in CLBT for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 92,270 shares. Largest reduction occurred in Q2 2025, reducing 42,798 shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Cellebrite DI (CLBT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Cellebrite DI (CLBT) Trades by Manning & Napier Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2025 | +101,848 | New Buy | 101,848 | $19.43 |
| Q2 2025 | -42,798 | Reduce 42.02% | 59,050 | $16.00 |
| Q3 2025 | +92,270 | Add 156.26% | 151,320 | $18.53 |
| Q4 2025 | -5,779 | Reduce 3.82% | 145,541 | $18.03 |
Manning & Napier Group's Cellebrite DI Investment FAQs
Manning & Napier Group first purchased Cellebrite DI Ltd. (CLBT) in Q1 2025, acquiring 101,848 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Cellebrite DI Ltd. (CLBT) for 4 quarters since Q1 2025.
Manning & Napier Group's largest addition to Cellebrite DI Ltd. (CLBT) was in Q1 2025, adding 101,848 shares worth $1.98 M.
According to the latest 13F filing for Q4 2025, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 145,541 shares of Cellebrite DI Ltd. (CLBT), valued at approximately $2.62 M.
As of the Q4 2025 filing, Cellebrite DI Ltd. (CLBT) represents approximately 0.03% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.
Manning & Napier Group's peak holding in Cellebrite DI Ltd. (CLBT) was 151,320 shares, as reported at the end of Q3 2025.